This page comprises a collection of publications authored or co-authored by members of the Bionetworking in Asia ESRC and ERC teams, providing an insight into the work of individual members, and the team as whole. Some publications are available to download.
Recent Team accepted publication:
Sleeboom-Faulkner, Margaret, Choon Key Chekar, Alex Faulkner, Carolyn Heitmeyer, Marina Marouda, Achim Rosemann, Nattaka Chaisinthop, Hung-Chieh (Jessica) Chang, Adrian Ely, Masae Kato, Prasanna K. Patra, Yeyang Su, Suli Sui, Wakana Suzuki, Xinqing Zhang (2016) Comparing National Home-Keeping and the Regulation of Transnational Stem Cell Applications: An International Perspective. Social Science and Medicine (In press).
Ely, A. and Scoones, I. (2009) The Global Redistribution of Innovation: Lessons from China and India, STEPS Working Paper 22, Brighton: STEPS Centre. - Click here for full article
Chen, Y. and Ely, A. (2011) Health Biotechnology Innovation for Social Sustainability - A Perspective from China, STEPS Working Paper 47, Brighton: STEPS Centre. - Click here for full article
Chang, Hung-Chieh. (2014) The third way of umbilical cord blood banking. Nature Biotechnology 32(4): 318 – 319. Click here for full article
Chang, Hung-Chieh. (2015) The normalisation of body gifting in Taiwan. BioSocieties 1745-8552: 1 -17. Click here for full article
(accepted) Heitmeyer, Carolyn. (2016) Biogovernance beyond the state?: The shaping of stem cell therapy by patient organisations in India. Medical Anthropology. Click here for full article
Patra, P.K. and Sleeboom-Faulkner, M. (2010). Bionetworking: between guidelines and practice in stem cell therapy enterprise in India. SCRIPTed – A Journal of Law, Technology and Society,7,295-310. - Read more (Published by SRIPTed under creative commons licence) Click here for full article
Patra, P.K. and Sleeboom-Faulkner, Margaret. (2009). Bionetworking: Experimental stem cell therapy and patient recruitment in India. Anthropology & Medicine 16(2): 147-163, 2009. Routledge, London. - Read more, Click here for full article
Patra, Prasanna Kumar and Sleeboom-Faulkner, Margaret. (2010). Informed consent and benefit sharing in genetic research and biobanking in India: some common impediments in practice. In Peter Dabrock, Jochen Taupits & Jens Ried (eds) Trust in Biobanking. Dealing with ethical, legal and social issues in an emerging field of biotechnology. London & New York: Springer. Chapter 11, pp. 121-136. Cick here to read more
Patra, Prasanna Kumar and Sleeboom-Faulkner, Margaret. (2009). Informed consent in genetic research and biobanking in India: some common impediments. Genomics, Society and Policy, Vol. 5, No.1, pp 100-113. Click here for full article
Patra, Prasanna Kumar and Sleeboom-Faulkner, Margaret. (2009). The Indian genomic biobank initiative and emerging bioethical issues: a community based perspective. In Human Genetic Biobanks in Asia: Politics of trust and scientific advancement, Routledge.
(accepted) Rosemann, Achim. (2016) Challenges to international stem cell clinical trials in countries with divergent regulations. In Phuc, VP (ed) Stem Cells in Clincal Applications: Safety, Ethics and Regulations. Heidelberg and London: Springer.
Rosemann, Achim, and Sleeboom-Faulkner, Margaret. (TBD) New regulation for clinical stem cell research in China: expected impact and challenges for implementation. Regenerative Medicine, 10 (6). ISSN 1746-0751 (In Press). Click here for full article
(accepted) Rosemann, Achim. (TBD) The pluralization of the international: networks of resistance and alter-standardization in regenerative stem cell medicine. Social Studies of Science, December 27, 2015. Click here for full article
Rosemann, Achim. (2015) Multi-country stem cell trials: the need for an international support structure. Stem Cell Research. ISSN 1873-5061 (In Press) Click here for full article
Rosemann, Achim. (2015) Stem cell treatments for neurodegenerative diseases: challenges from a science, business and healthcare perspective, Neurodegenerative Disease Management, 5(2), pp. 85-87. (2015). Click here for full article
Rosemann, Achim. (2015) Modalities of value, exchange, solidarity: the social life of stem cells in China, in: M. Sleeboom-Faulkner (Ed.) Stem Cell Research in Asia: Looking beyond regulatory exteriors. London/New York: Routledge. Click here to read more
Rosemann, Achim. (2014) Standardization as situation-specific achievement: Regulatory diversity and the production of value in intercontinental collaborations in stem cell medicine, Social Science & Medicine, 122, pp. 72 -80. Click here for full article
Rosemann, Achim. (2014) Why regenerative stem cell medicine progresses slower than expected, Journal of Cellular Biochemistry. DOI: 10.1002/jcb.24894 Click here for full article
Rosemann, Achim. (2013) Scientific Multipolarization: Its impact on international clinical research collaborations and theoretical implications, Science Technology and Society, 18(3), pp. 339-359. Click here for full article
Rosemann, Achim. (2013) Medical Innovation and National Experimental Pluralism: Insights from Clinical Stem Cell Research and Applications in China, Biosocieties, 8(1), pp. 58-74. Click here for full article
Rosemann, Achim. (2012) Multi-polar Technoscience: Clinical Science Collaborations in a Changing World System, PhD Dissertation.
Rosemann, Achim. (2011) Modalities of Value, Exchange, Solidarity: Exploring the Social Life of Stem Cells in China, New Genetics and Society, Vol. 30, No. 2, pp. 181-192. Click here for full article
Rosemann, Achim. (2009) The IVF-Stem Cell Interface in China: Ontologies, Value-perceptions and Donation-practices of Embryonic Forms of Life, in O. Doering (ed.), Life Sciences in Translation - A Sino-European Dialogue on Ethical Governance of the Life Sciences, BIONET, Online Textbook, delivery to the EU Commission, pp. 168-179. Click here for full chapter
Rosemann, Achim. (2009) Life without Value? Listening to the voices of embryo donors for human embryonic stem cell research in China, IIAS Newsletter, No 52, winter 2009, pp. 15-6. Click here for full article
Sleeboom-Faulkner, Margaret. (2016). The large grey area between ‘bona fide’ and ‘rogue’ stem cell interventions — Ethical acceptability and the need to include local variability, Technological Forecasting and Social Change, 109: 76-86. Click here for full article
Sleeboom-Faulkner, Margaret and Sui, Suli. (2015). Commercial Genetic Testing and its Governance in Chinese Society. Minerva, 53. pp. 215-234. Click here for full article
Sleeboom-Faulkner, Margaret. (2014). The ‘Good’ Child: anthropological perspectives on morality and childhood. The Journal for Moral Education, 43 (2). ISSN 0305-7240 (with Meike Fechter). Click here for full article
Sleeboom-Faulkner, Margaret. (2014). Bioethical governance in South Korea: tensions between bottom-up movements and professionalization, and scientific citizenship. East Asia Journal for Science and Technology Studies (EASTS), 8(2): 209-228 with Seyoung Hwang (major contributor). Click here for full article
Sleeboom-Faulkner, Margaret. (2013). Regulating ‘respect’ for the embryo: Social mindscapes and human embryonic stem cell research in Japan. Science, Technology and Society, November 2013 vol. 18 no. 3 361-377. Click here for full article
Sleeboom-Faulkner, Margaret. (2013). Regulating ‘respect’ for the embryo: Social mindscapes and human embryonic stem cell research in Japan. Social Science & Medicine, Ayo Wahlberg, Christoph Rehmann-Sutter, Margaret Sleeboom-Faulkner, Guangxiu Lu, Ole Döring, Yali Cong, Alicja Laska-Formejster, Jing He, Haidan Chen, Herbert Gottweis. Dec 2013, 98: 293-300. Click here for full article
Sleeboom-Faulkner, Margaret. (2013). Regulating ‘respect’ for the embryo: Social mindscapes and human embryonic stem cell research in Japan. Biosocieties, 8, 75-92 with Prasanna K. Patra (major contributor). Click here for full article
Sleeboom-Faulkner, Margaret. (2013). Introduction to ‘Experimental Ethics’, Biosocieties, 8: 1-7. [SSCI 2.192]
Sleeboom-Faulkner, Margaret. (2013). The (in)visibility of women’s work, efforts and experiences in embryo donation: The Case of Japan. Gender, Place and Culture 20 (6) 737-53.[SSCI, 1.030] with Masae Kato. Click here for full article
Sleeboom-Faulkner, Margaret. (2013). The Harvard case of Xu Xiping: Exploitation of the people, scientific advance or genetic theft? In: Jagannath Dash, Prasanna Kumar Patra, Kanhu Charan Satapathy (eds.) Dimensions of Healthcare Systems Among Tribal and Other Communities. Odisha: Utkal Univesrity. Pp: 29-61.
Sleeboom-Faulkner, Margaret and Hwang, Seyoung.(2012). Governance of stem cell research: public participation and decision-making in China, Japan, South-Korea, Taiwan and the UK. Social Studies of Science，No. 42, Vol. 4, pp. 1-25. Click here for full article
Sleeboom-Faulkner, Margaret.(2011). Stem Cell Research in Asia: Looking beyond formal regulatory exteriors. New Genetics and Society, No. 2 and 3, Double Special Issue. Routledge, London. Click here for full article
Sleeboom-Faulkner, Margaret and Patra, Prasanna K.(2011). Experimental stem cell therapy: Biohierarchies and bionetworking in Japan and India. Social Studies of Science, 41(5), October 2011, pp. 696-707. - Click here for full article
Sleeboom-Faulkner, Margaret.(2011). Stem Cell Research in Asia: Looking beyond formal regulatory exteriors. New Genetics and Society, Vol. 30, No. 3, pp. 279-288, (Special Issue). Routledge, London. - Click here for full article
Sleeboom-Faulkner, Margaret.(2011). Regulating Cell Lives in Japan: Avoiding Scandal & Sticking to Nature. New Genetics and Society, No. 3, 2011, pp. 227-240. Routledge, London. Click here for full article
Sleeboom-Faulkner, Margaret.（2010). National Risk Signatures and Human Embryonic Stem Cell Research in Mainland China. Health, Risk and Society, Vol. 12, Issue 5 October 2010, pp. 491 – 511. Routledge, London. Click here for full article
Sleeboom-Faulkner, Margaret.（2010. Boundary making and good stem cell research MSF 2010. East Asia Journal for Science and Technology Studies (EASTS), Vol. 4, Issue 1, pp 31-51. Click here for full article
Sleeboom-Faulkner,Margaret. (2009). Human Genetic Biobanks in Asia: Politics of Trust and Scientific Advancement. London: Routledge.
Sleeboom-Faulkner, Margaret . (2009). Biobanking in Transnational Perspective. In Ole Doering (ed.) Ethical Governance of Biological and Biomedical Research: Chinese-European Co-operation, Ch. 3: pp. 28-32.
Sleeboom-Faulkner, Margaret . (2009). Human Genetic Biobanking in Asia: Issues of Trust, Wealth and Ambition. In Margaret Sleeboom-Faulkner (ed.) Human Genetic Biobanks in Asia: Politics of trust and scientific advancement. Routledge. Click here to read more
Sleeboom-Faulkner, Margaret. and Patra, P.K.(2008). The Bioethical Vacuum: National Policies on Human Embryonic Stem Cell Research in India and China. Journal of International Biotechnology Law [JIBL] 5(6): 221-234, December. De Gruyter, Berlin. Click here for full article
Sleeboom-Faulkner, Margaret.（2008). The changing nature of ideology in the life sciences in the People’s Republic of China (PRC). Case studies of human cloning and human embryonic stem cell research (hESR) in medical textbooks (1996-2005). Biosocieties, Vol. 3, April, pp. 21-36. Palgrave Macmillan, Basingstoke. Click here for full article
Sleeboom-Faulkner, Margaret.（2008). Debates on Human Embryonic Stem Cell Research in Japan: Minority Voices and their Amplifiers. Science as Culture, 17(1) March, pp. 85-97. Routledge, London.- Click here for full article
Sleeboom-Faulkner, Margaret. (2007). Collecting families: An institutional approach to human genetic biobanking in Indonesia. In The Asian Social Science Journal, 36(1), pp. 626-656. Click here for full article
Su, Yeyang
Su Y. Learning from and working with the diabetes patients for patient advocacy. Chinese Journal of Diabetes. 2015, 23(3): 193-194. Click here for full article
Sui, Suli and Sleeboom-Faulkner, Margaret. (2015). Commercial Genetic Testing and its Governance in Chinese Society. Minerva, 53. pp. 215-234. Click here for full article
Sui, Suli. (2014). The cord blood bank and its related issues in China. (In Chinese) Chinese Journal of Family Planning, (2014) Volume 22 No. 4. pp. 220-4.
Sui, Suli (2014). Is stem cell therapy a lifesaver? Patients' experiences of and views on stem cell therapy in China. The Innovia Foundation Newsletter, July 2014(23), pp. 8-11. Click here to read more
Sui, Suli (2013). The Understanding on the Governance of Stem Cell in China. Journal of China Hospital CEO, 2013 (5), pp. 74-5.
Sui, Suli and Sleeboom-Faulkner, Margaret (2010). Choosing offspring: prenatal genetic testing for thalassaemia and the production of a ‘saviour sibling’ in China. Culture, Health & Sexuality, Vol. 12, No. 2, pp.167-175. Routleadge, London.- Click here to read more
Wang, Li., Zhang, Xinqing and Qiu, Ren.(2011). Ethical Reflection on Epidemiological Research in China. Chinese Medical Ethics, Vol. 24, No. 3. - Click here to read more
Li, Zhao-yi., Wang, Zhi-jie., Zhang, Xinqing. and Liu, Xue-ying.(2009).Causes and Countermeasures of Violent Trespass against Medical Right. Chinese Medical Ethics, Vol. 22, No. 4. - Click here to read more
Matsui, Kenji., Abou Zeid, Alaa., Zhang, Xinqing et al. (2009). ‘Informed Consent to Future Research on Stored Tissue Samples: the Views of Researchers, Ethics Review Committee Members and Policy Makers in Five Non-Western Countries’. Asian Bioethics Review, Vol. 1, Issue 4, pp. 401-416. - Click here to read more
Xinqing, Zhang. (2008). Gene Therapy in PR China: Regulations and Ethical Concerns. Journal of International Biotechnology Law [JIBL], Vol. 2, Issue 5, pp. 212–216. De Gruyter. - Click here to read more
Zhang, Xinqing., Fan, Chun-liang. and Chen, Qi. (2007). Ethical Reflection on the sources of Human Embryonic Stem Cell .Chinese Medical Ethics, Vol. 20, No. 6. - Click here to read more